Ubrogepant (Ubrelvy—Allergan) has received FDA approval as the first oral calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine with or without aura in adults.

Cara Aldridge Young

The American Heart Association (AHA) and the American College of Cardiology (ACC) jointly released a set of performance and quality measures for adults with high blood pressure that closely align with AHA/ACC’s blood pressure guidelines published in late 2017.

Loren Bonner

All pharmacists know that for many conditions, medication isn’t enough. True management of chronic diseases takes a 360° approach that includes exercise, smoking cessation, and—unavoidably—nutrition.

Rachel Balick

Cough—a symptom of diverse infectious and noninfectious disorders that is classified as acute (<3 weeks), subacute (3–8 weeks), or chronic (>8 weeks)—is an important defensive respiratory reflex with potentially significant adverse physical and psychological consequences and economic impact.

Daniel L. Krinsky, RPh, MS

Updates from FDA